<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230722058889N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-23</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>A comparative study of the effectiveness of two treatment methods, dry needling and kinesiotaping, in the treatment of tennis elbow</public_title>
      <acronym></acronym>
      <scientific_title>A comparative study of the effectiveness of two treatment methods, dry needling and kinesiotaping, in the treatment of tennis elbow</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>62</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72086</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization is done in a simple way, individual randomization unit and using statistical software, Blinding description: Allocation of patients to two treatment groups is done randomly using spss version 22 software.The blinding is two-way, and the main implementer of the design and the data analyzer are not aware of the order of placing people in the clinical groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>lateral epicondilitis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Dry needling method:The first group is treated with dry needling and exercise and a non-steroidal anti-inflammatory drug (Meloxicam 15 mg daily) for three weeks. The position is neutral. After cleaning the skin with 70% isopropyl alcohol, a needle with a size of 0.25 x 25 in the lateral epicondyle and at the point of maximum pain using the Hong fast-in-fast-out method 20 times in a specific place It is moved for 20 seconds and the Chou technique is also used to facilitate the movement of the needle by rotating at the same time when inserting and removing the needle. This work is done twice a week for 3 weeks and a total of 6 sessions. Intervention 2: Intervention group: Kinesio taping:The second group is treated with kinesio taping and exercise and a non-steroidal anti-inflammatory drug (Meloxicam 15 mg daily) for three weeks. We glue near the end of the muscles so that the volume of the extensor carpi radialis brevis, extensor carpi radialis longus, and extensor carpi ulnaris muscles is placed between the two arms of the glue. The beginning and end of the glue is done without tension and the middle of the glue is done with medium tension, which works with a restraining mechanism.Then we stick an I-shaped strip with a width of 5 cm and a length of 10 cm on the outer part of the elbow so that the middle stretch part of the adhesive is placed on the point of the most pain and the two sides of the adhesive are without tension, which can be removed with the space correction mechanism. Weight is applied. Then, an I-shaped band with a width of 5 cm and a length of 10 cm is attached with a medium tension from the inside of the elbow to the outside in the anatomical position of the body while the muscle is pushed outward with the fascia correction technique. During these procedures, the patient's elbow is in extension, and the wrist is in pronation, flexion, and ulnar deviation. This work is done twice a week for 3 weeks and a total of 6 sessions.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after de-identifying individuals.

When:
The access period starts 6 months after the results are published

To whom:
It will be available only to researchers working in academic and scientific institutions.

Conditions:
There are no other conditions.

Where to obtain:
Send the request to mozr88@yahoo.com.

How to obtain:
After 1 month, the documents or data files will reach her or him.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Razieh Maghruri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Al-Zahra Hospital, Sefe Blvd., Aghareb Parast Highway</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174675731</zip>
        <telephone>+98 31 3668 5555</telephone>
        <email>ramaghroori@yahoo.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Razieh Maghruri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Al-Zahra Hospital, Sefe Blvd., Aghareb Parast Highway</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174675731</zip>
        <telephone>+98 31 3668 5555</telephone>
        <email>ramaghroori@yahoo.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 30 to 65 years
Pain in the lateral epicondyle for at least a month
Pain in cozen's test
Pain in the extensor carpi radialis test (that is, resistance to the extension of the middle finger - Maudsley's test)
Supination resistance test (Mill's test)</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Diabetes Mellitus
Cervical radiculopathy
Bilateral lateral epicondylitis neuropathy
Arthritis in the upper limb or a history of arthritis
Bilateral lateral epicondylitis
pregnancy
History of forearm and elbow surgery
Acute elbow trauma
Allergy to Kinesiology tape
Cubital tunnel syndrome
Carpal tunnel syndrome
autoimmune disease
Rotator cuff tendonitis
Local or systemic upper limb infection
Fibromyalgia syndrome
Medial epicondylitis of the same side
An old fracture in the damaged arm
Changing the shape of the elbow
Coagulation diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M77.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Lateral epicondylitis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Dry needling method:The first group is treated with dry needling and exercise and a non-steroidal anti-inflammatory drug (Meloxicam 15 mg daily) for three weeks. The position is neutral. After cleaning the skin with 70% isopropyl alcohol, a needle with a size of 0.25 x 25 in the lateral epicondyle and at the point of maximum pain using the Hong fast-in-fast-out method 20 times in a specific place It is moved for 20 seconds and the Chou technique is also used to facilitate the movement of the needle by rotating at the same time when inserting and removing the needle. This work is done twice a week for 3 weeks and a total of 6 sessions.</i_keyword>
      <i_keyword>Intervention group: Kinesio taping:The second group is treated with kinesio taping and exercise and a non-steroidal anti-inflammatory drug (Meloxicam 15 mg daily) for three weeks. We glue near the end of the muscles so that the volume of the extensor carpi radialis brevis, extensor carpi radialis longus, and extensor carpi ulnaris muscles is placed between the two arms of the glue. The beginning and end of the glue is done without tension and the middle of the glue is done with medium tension, which works with a restraining mechanism.Then we stick an I-shaped strip with a width of 5 cm and a length of 10 cm on the outer part of the elbow so that the middle stretch part of the adhesive is placed on the point of the most pain and the two sides of the adhesive are without tension, which can be removed with the space correction mechanism. Weight is applied. Then, an I-shaped band with a width of 5 cm and a length of 10 cm is attached with a medium tension from the inside of the elbow to the outside in the anatomical position of the body while the muscle is pushed outward with the fascia correction technique. During these procedures, the patient's elbow is in extension, and the wrist is in pronation, flexion, and ulnar deviation. This work is done twice a week for 3 weeks and a total of 6 sessions.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain score. Timepoint: Before performing the treatment methods and in the 3rd and 8th weeks after the treatment. Method of measurement: Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Functional status. Timepoint: Before performing the treatment methods and in the 3rd and 8th weeks after the treatment. Method of measurement: Patient Rating Forearm Evaluation Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-06-26</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Al-Zahra Hospital, Sefe Blvd, Aghareb parast highway. Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
